CMAC
Home
Journal Archive
Subscription
About
About
Author Guidelines
Editorial Board
Peer Review
Publishing Ethics
English
Русский
CMAC 2026; 28(2)
Type
Review
Clinical Case
Expert opinion
Original Article
Sections
Antimicrobial Resistance
Antimicrobials
Clinical Cases
Diseases and Pathogens
Personal Experience
Development of a molecular typing scheme for
Chlamydia trachomatis
based on the analysis of highly variable genomic loci
Objective. To develop a molecular typing scheme for Chlamydia trachomatis to enable molecular epidemiological monitoring of this …
Nosov N.Yu.
,
Nikonorova E.R.
,
Solomka V.S.
,
Plakhova K.I.
Clinical Microbiology and Antimicrobial Chemotherapy. 2026; 28(2):148-169
10.36488/cmac.2026.2.148-169
PDF
Cite
Two-level combined probiotics – a new paradigm for the prevention of respiratory tract infections and antibiotic-associated conditions
In light of the widespread growth of antimicrobial resistance, the decline in the effectiveness of existing antibiotics, and the global …
Andreeva I.V.
,
Andreev V.A.
,
Dovgan E.V.
,
Karpova E.P.
,
Ovchinnikov A.Yu.
,
Selimzyanova L.R.
,
Stetsiouk O.U.
Clinical Microbiology and Antimicrobial Chemotherapy. 2026; 28(2):171-186
10.36488/cmac.2026.2.171-186
PDF
Cite
Ceftobiprole: an update on microbiological activity, clinical efficacy, and safety across diverse patient populations (a literature review)
This review presents current data on the microbiological activity, efficacy, and safety of the fifth-generation semisynthetic …
Zubareva N.A.
,
Parshakov A.A.
,
Popov D.A.
Clinical Microbiology and Antimicrobial Chemotherapy. 2026; 28(2):187-193
10.36488/cmac.2026.2.187-193
PDF
Cite
Biapenem use in pediatric patients: current state of knowledge
Biapenem, in combination with polymyxin and/or tigecycline, has promising potential in the treatment of severe infections in children, …
Kostina A.V.
,
Kostyleva M.N.
,
Strok A.B.
,
Petryaykina E.E.
,
Zyryanov S.K.
Clinical Microbiology and Antimicrobial Chemotherapy. 2026; 28(2):195-202
10.36488/cmac.2026.2.195-202
PDF
Cite
Antibiotics and probiotics: old challenges and novel decisions. Resolution of Summit of Exper ts
On March 28, 2026, an expert summit titled «Antibiotics and Probiotics: Old Challenges and New Solutions,» organized by …
Gorelov A.V.
,
Kozlov R.S.
,
Livzan M.A.
,
Andreeva I.V.
,
Bavykina I.A.
,
Baylova O.P.
,
Bikbavova G.R.
,
Bondar G.N.
,
Dovgan E.V.
,
Dondurey E.A.
,
Ermakov A.M.
,
Ermolenko K.D.
,
Ermolenko K.Yu.
,
Zaitsev A.V.
,
Zakharenko S.M.
,
Zolnikova O.Yu.
,
Zorina L.A.
,
Zyryanov S.K.
,
Kachkovsky M.A.
,
Kulygina Yu.A.
,
Lozko N.I.
,
Osipenko M.F.
,
Pinelis M.L.
,
Privorotsky V.F.
,
Repetskaya M.N.
,
Ryazantsev S.V.
,
Sagitova G.R.
,
Stetsyuk O.U.
,
Trofimenko I.N.
,
Usenko D.V.
,
Fesenko O.V.
,
Khamitov R.F.
,
Chemisova O.S.
,
Shabalov A.M.
,
Shatalina S.I.
,
Shebeko S.K.
,
Shevyakov M.A.
,
Yakovleva L.V.
Clinical Microbiology and Antimicrobial Chemotherapy. 2026; 28(2):203-208
10.36488/cmac.2026.2.203-208
PDF
Cite
Risk factors and prediction models for the presence of bacterial pathogens with clinically significant antimicrobial resistance phenotypes: a systematic review
Objective. To systematically synthesize factors associated with the presence, colonization, infection, or acquisition of bacterial …
Kuzmenkov A.Yu.
,
Gultiaeva N.A.
,
Vinogradova A.G.
,
Meshchurova S.Yu.
,
Babicheva A.I.
Clinical Microbiology and Antimicrobial Chemotherapy. 2026; 28(2):209-240
10.36488/cmac.2026.2.209-240
PDF
Cite
Genetic mechanisms of
in vitro
-induced flucytosine resistance in Candidozyma auris
Objective. To develop an in vitro model for the development of Candidozyma auris resistance to flucytosine (5-FC) and characterize its …
Oganesyan E.G.
,
Gusarova K.V.
,
Kovyrshin S.V.
,
Zhuk A.S.
,
Taraskina A.E.
,
Lyubimova A.V.
,
Vasilyeva N.V.
Clinical Microbiology and Antimicrobial Chemotherapy. 2026; 28(2):241-251
10.36488/cmac.2026.2.241-251
PDF
Cite
Comparative analysis of antimicrobial susceptibility testing results and applied interpretive standards in Russian Federation medical organizations
Objective. To assess the categorization of antimicrobial susceptibility testing results using aggregated data from microbiology …
Vinogradova A.G.
,
Kuzmenkov A.Yu.
,
Trushin I.V.
,
Kozlov R.S.
Clinical Microbiology and Antimicrobial Chemotherapy. 2026; 28(2):253-263
10.36488/cmac.2026.2.253-263
PDF
Cite
Population pharmacokinetic/pharmacodynamic modeling of linezolid in critically ill adult patients
Objective. To evaluate pharmacokinetics using therapeutic drug monitoring (TDM) data and develop a population …
Bondareva I.B.
,
Zyryanov S.K.
,
Chenkurov M.S.
,
Putsman G.A.
,
Savotskaya A.M.
Clinical Microbiology and Antimicrobial Chemotherapy. 2026; 28(2):264-278
10.36488/cmac.2026.2.264-278
PDF
Cite
Knowledge architecture in antimicrobial therapy: from cluster stratification to correlation map
Objective. To conduct an in-depth analysis of the competence structure in rational antimicrobial therapy (AMT) among healthcare …
Bontsevich R.A.
Clinical Microbiology and Antimicrobial Chemotherapy. 2026; 28(2):279-289
10.36488/cmac.2026.2.279-289
PDF
Cite
Whole-genome analysis of a probiotic strain Lactocaseibacillus – identification of genetic determinants for bacteriocin production as a basis for standardization of mono- and multicomponent probiotics
Objective. Conducting a whole-genome study and bioinformatic analysis of a Lacticaseibacillus strain to confirm taxonomic affiliation, …
Bozhkova A.G.
,
Shimanovsky N.L.
,
Melkumyan A.R.
,
Chistyakova D.A.
,
Alekseev M.V.
,
Achkasov S.I.
Clinical Microbiology and Antimicrobial Chemotherapy. 2026; 28(2):290-300
10.36488/cmac.2026.2.290-300
PDF
Cite
Molecular genetic features and prevalence of tetracycline resistance genes in Salmonella enterica
Objective. To assess prevalence of genetic determinants of tetracycline resistance (tetA, tetB, tetC) in Salmonella in the Krasnoyarsk …
Reshetneva I.T.
,
Rukosueva T.V.
,
Peryanova O.V.
Clinical Microbiology and Antimicrobial Chemotherapy. 2026; 28(2):301-308
10.36488/cmac.2026.2.301-308
PDF
Cite
Monitoring of macrolide resistance in
Mycoplasma pneumoniae
isolated from children in Smolensk region in 2009–2024: DeMaRes study
Objective. To study prevalence of macrolide resistance mutations in Mycoplasma pneumoniae isolated from children with …
Kozlova E.Yu.
,
Edelstein I.A.
,
Pleskachevskaya T.A.
,
Novikova O.B.
,
Shalkina L.A.
,
Kornyushina V.M.
,
Romanov A.V.
,
Kozlov R.S.
Clinical Microbiology and Antimicrobial Chemotherapy. 2026; 28(2):309-319
10.36488/cmac.2026.2.309-319
PDF
Cite
Local experience in adapting «SCAT 2025» scale for risk stratification of resistant pathogens and selection of initial empirical antimicrobial therapy in a multispecialty children’s hospital
Objective. To develop and perform pilot prospective validation of a locally adapted pediatric version of the SCAT scale for risk …
Vlasova A.V.
,
Gorev V.V.
,
Lukash U.V.
,
Smirnova E.V.
,
Volkova N.N.
,
Gorokhov D.V.
,
Bystrova А.А.
,
Brunova O.Yu.
,
Valieva S.I.
,
Tenovskaya Т.А.
,
Rtishchev A.Yu.
,
Sorokin E.V.
,
Dzhandarova D.T.
,
Komarov A.G.
Clinical Microbiology and Antimicrobial Chemotherapy. 2026; 28(2):320-329
10.36488/cmac.2026.2.320-329
PDF
Cite
Treatment of disseminated mycobacteriosis caused by
Mycobacterium avium
in HIV patients using bedaquiline: clinical examples
Three clinical cases of treatment of patients with disseminated mycobacteriosis caused by
M. avium
using the drug bedaquilin have been …
Veselova E.I.
,
Kuznetsova E.N.
,
Zilfova D.I.
,
Peregudova A.B.
,
Tinkova V.V.
,
Vasilieva I.A.
Clinical Microbiology and Antimicrobial Chemotherapy. 2026; 28(2):330-337
10.36488/cmac.2026.2.330-337
PDF
Cite
Sepsis caused by Lactobacillus: a clinical case report
The article describes a clinical observation of a 3 months old patient with ALK-positive histiocytosis complicated by sepsis caused by …
Demchenkova M.V.
,
Semshchikova Yu.P.
,
Barzunova T.V.
,
Kozlov Yu.A.
,
Savintseva I.N.
Clinical Microbiology and Antimicrobial Chemotherapy. 2026; 28(2):338-343
10.36488/cmac.2026.2.338-343
PDF
Cite
Compassionate-use rezafungin for proven deep-seated invasive candidiasis caused by Candidozyma auris: a clinical case report
Candidozyma auris (
Candida auris
before 2024) is a fungus included in the list of priority fungal pathogens by the World Health …
Andreev S.S.
,
Yatskov K.V.
,
Ryazantseva E.V.
,
Isaev T.K.
,
Trushkin R.N.
,
Kuznetsova D.S.
,
Zhelnova E.I.
,
Lysenko M.A.
Clinical Microbiology and Antimicrobial Chemotherapy. 2026; 28(2):344-352
10.36488/cmac.2026.2.344-352
PDF
Cite
Cite
×
